Research articlePublished 3 May 2019
UPLC method for the quantitative estimation of emtricitabine impurities in formulated drug product
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A simple, faster reverse phase UPLC method has been developed for quantitative estimation of Emtricitabine impurities in pharmaceutical dosage form. Emtricitabine is an antiretroviral compound that inhibits the HIV-1 reverse transcriptase. Chromatographic separation was achieved on Waters Acquity UPLC BEH C8 , 100x 2.1 mm ,1.7μm column in a gradient mode elution. Detection wavelength was set at 270 nm. Drug product was subjected for stress conditions of Acid, Alkali and Peroxide degradation. Emtricitabine was found to have degraded significantly in peroxide condition. Peak purity results of Emtricitabine indicated that all degradents are separated from the analyte peak. The developed method was validated as per ICH guidelines with respect to Specificity, Linearity, Accuracy, Precision, Limit of detection and quantification.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDer Pharmacia Lettre
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sreekanth Nadig”
- BylineArticles whose byline prints “Jane T Jacob”